Literature DB >> 20227832

The burden of neuropathic pain: a systematic review and meta-analysis of health utilities.

Alissa H Doth1, Per T Hansson, Mark P Jensen, Rod S Taylor.   

Abstract

Patients with neuropathic pain (NeuP) experience substantially lower health-related quality of life (HRQoL) than the general population. The aim of this systematic review and meta-analysis is to test the hypothesis that NeuP is associated with low levels of health utility. A structured search of electronic databases (MEDLINE, EMBASE, Cochrane Library and CINAHL) was undertaken. Reference lists of retrieved reports were also reviewed. Studies reporting utility single-index measures (preference based) in NeuP were included. Random effects meta-analysis was used to pool EQ-5D index utility estimates across NeuP conditions. The association of utilities and pre-defined factors (NeuP condition, patient age, sex, duration and severity of pain and method of utility scoring) was examined using meta-regression. Twenty-four studies reporting health utility values in patients with NeuP were included in the review. Weighted pooled utility score across the studies varied from a mean of 0.15 for failed back surgery syndrome to 0.61 for post-herpetic neuralgia and diabetic neuropathy. Although there was substantial heterogeneity (P<0.0001) across studies, we found little variation in utility as a function of patient and study characteristics. The single exception was a significant relationship (P<0.0001) between increasing neuropathic pain severity and a reduction in utility. This study confirms the hypothesis that patients with NeuP experience low utilities and therefore low HRQoL. However, the contribution of non-NeuP co-morbidity remains unclear. Neuropathic pain severity emerged as a primary predictor of the negative health impact of NeuP. Copyright 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20227832     DOI: 10.1016/j.pain.2010.02.034

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  86 in total

Review 1.  Epidural steroid injections.

Authors:  Indy M Wilkinson; Steven P Cohen
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 3.  Psychological therapies for the management of chronic neuropathic pain in adults.

Authors:  Christopher Eccleston; Leslie Hearn; Amanda C de C Williams
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

4.  The economic impact of failed back surgery syndrome.

Authors:  Rod S Taylor; Rebecca J Taylor
Journal:  Br J Pain       Date:  2012-11

5.  Intrathecal Administration of Tempol Reduces Chronic Constriction Injury-Induced Neuropathic Pain in Rats by Increasing SOD Activity and Inhibiting NGF Expression.

Authors:  Baisong Zhao; Yongying Pan; Zixin Wang; Yonghong Tan; Xingrong Song
Journal:  Cell Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.046

Review 6.  The Identification, Review and Synthesis of Health State Utility Values from the Literature.

Authors:  Roberta Ara; John Brazier; Tessa Peasgood; Suzy Paisley
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

7.  Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review.

Authors:  Natalia Ruiz-Negrón; Jyothi Menon; Jordan B King; Junjie Ma; Brandon K Bellows
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

8.  Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.

Authors:  Setsuro Ogawa; Akio Arakawa; Kazuhiro Hayakawa; Tamotsu Yoshiyama
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

Review 9.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

10.  Responses to the McGill Pain Questionnaire predict neuropathic pain medication use in women in with vulvar lichen sclerosus.

Authors:  Mitchell B Berger; Nicholas J Damico; Hope K Haefner
Journal:  J Low Genit Tract Dis       Date:  2015-04       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.